Company or institution

KUDOS PHARMACEUTICALS LIMITED

Save Like

32 applicationsfiled 2007 to 2024

Allowance rate

59%

−16 pts vs the USPTO range 42% to 74%

Rejections before allowance

1.0

−0.6 vs the USPTO

Months to first action

13.4 mo

−5.2 vs the USPTO

Needed an RCE

13%

−15 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations23 apps

C07D Heterocyclic compounds8 apps

Art units

162412 apps

16117 apps

16265 apps

16273 apps

16342 apps

16281 apps

Examiners met

The examiners seen most, and how it went with each

Paul V Ward8 apps

75%

Peter Anthopolos7 apps

86%

Rebecca L Anderson5 apps

100%

Cecilia M Jaisle5 apps

20%

Stephen Thomas Kapushoc3 apps

Kendra D Carter1 apps

Dennis Heyer1 apps

100%

Samira Jm Jean-Louis1 apps

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

MICHAEL BEST & FRIEDRICH LLP (Mad)8 apps

25%

ASTRAZENECA MEDIMMUNE6 apps

100%

Casimir Jones, S.C.5 apps

80%

Finnegan/AstraZeneca4 apps

100%

FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER4 apps

75%

BOZICEVIC, FIELD & FRANCIS LLP3 apps

Morgan, Lewis & Bockius LLP (WA)2 apps

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
18785063	IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERA…	2024-07-26	Allowed	0	0	2.1 mo
18785092	IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERA…	2024-07-26	Allowed	0	0	1.9 mo
18755544	IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERA…	2024-06-26	Abandoned	0	0	n/a
15749725	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15505234	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15557345	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15905735	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15481832	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15203403	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15362143	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 32 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in